跳至主要内容
临床试验/NCT02430857
NCT02430857Unknown不适用

Osteopathy and Latent Hypothyroidism: Effectiveness of Osteopathic Treatment on TSH in Patients With Latent Hypothyroidism

Emanuel Amier Diekmann0 个研究点目标入组 40 人开始时间: 2015年10月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
40
主要终点
Change in TSH Concentration

研究概览

简要总结

This study evaluates the effectiveness of stimulating the neurological segments c8-th5 in patients with latent hypothyroidism.

One half of the participants will receive an osteopathic manuel treatment in order to stimulate the relevant segments, the other half will receive no treatment.

详细描述

Patients with latent hypothyroidism show an increased hormone status in TSH and a normal hormone status in fT4. A study has shown that osteopathic treatment had positive effects to some symptoms in patients with latent hypothyroidism. The study was using the pain inventory as the instrument to measure the effect. In this study we want to evaluate the effectiveness of the treatment on the hormone status (TSH, fT4) The intervention group will receive a neurological osteopathic stimulation over 5 weeks. A parallel control group will not receive any therapy.

A follow up blood screening (TSH, fT4) will be done. The results of both groups will be compared.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • latent hypothyroidism

排除标准

  • Factors that Alter Thyroxine and Triiodothyronine Binding in Serum
  • Increased thyroxin-binding globulin
  • Decreased thyroxin-binding globulin
  • Binding inhibitors
  • Inherited Salicylates
  • Pregnancy
  • Androgens
  • Furosemide
  • Neonatal state
  • Anabolic steroids
  • Free fatty acids
  • Estrogens
  • Glucocorticoids
  • Phenytoin
  • Hepatitis
  • Severe illness
  • Carbamazepine
  • Porphyria
  • Hepatic failure
  • nonsteroidal antiinflammatory drug (variable, transient)
  • Nephrosis
  • Methadone
  • Nicotinic acid
  • Mitotane L-Asparaginase
  • 5-Fluorouracil
  • SERMS (e.g., tamoxifen, raloxifene)
  • Perphenazine
  • spinal pathologies

结局指标

主要结局

Change in TSH Concentration

时间窗: 5 weeks

次要结局

未报告次要终点

研究者

发起方
Emanuel Amier Diekmann
申办方类型
Indiv
责任方
Sponsor Investigator
主要研究者

Emanuel Amier Diekmann

DO

Diekmann, Emanuel Amier

相似试验